[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69(1): 7-34. DOI: 10.3322/caac.21551.
[2] Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? [J].Cancer Commun (Lond), 2019, 39(1): 22. DOI: 10.1186/s40880-019-0368-6.
[3] BenAissa R, Othman H, Villard C, et al. AaHIV a sodium channel scorpion toxin inhibits the proliferation of DU145 prostate cancer cells[J]. Biochem Biophys Res Commun, 2020, 521(2):340-346. DOI: 10.1016/j.bbrc.2019.10.115.
[4] Xiang Y, Guo Z, Zhu P, et al. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science[J]. Cancer Med, 2019, 8(5):1958-1975. DOI: 10.1002/cam4.2108.
[5] Jiang H, Li J, Wang L, et al. Total glucosides of paeony: a review of its phytochemistry, role in autoimmune diseases, and mechanisms of action[J]. J Ethnopharmacol, 2020, 258:112913. DOI: 10.1016/j.jep.2020.112913.
[6] Yang S, Shen T, Zhao L, et al. Chemical constituents of Lobelia chinensis[J]. Fitoterapia, 2014, 93:168-74. DOI: 10.1016/j.fitote.2014.01.007.
[7] Luo TT, Lu Y, Yan SK,et al. Network pharmacology in research of Chinese medicine formula: methodology, application and prospective[J]. Chin J Integr Med, 2020, 26(1):72-80. DOI: 10.1007/s11655-019-3064-0.
[8] Gao J, Yang S, Xie G, et al. Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of aloin against gastric cancer[J]. Drug Des Devel Ther, 2022, 16:1947-1961. DOI: 10.2147/DDDT.S360790.
[9] Shree A, Islam J, Sultana S. Quercetin ameliorates reactive oxygen species generation, inflammation, mucus depletion, goblet disintegration, and tumor multiplicity in colon cancer: probable role of adenomatous polyposis coli, β-catenin[J]. Phytother Res, 2021, 35(4):2171-2184. DO: 10.1002/ptr.6969.
[10] Yoo HS, Won SB, Kwon YH. Luteolin induces apoptosis and autophagy in HCT116 colon cancer cells via p53-dependent pathway[J]. Nutr Cancer, 2022, 74(2):677-686. DOI: 10.1080/01635581.2021.1903947.
[11] Wu H, Cui M, Li C,et al. Kaempferol reverses aerobic glycolysis via miR-339-5p-mediated PKM alternative splicing in colon cancer cells[J]. J Agric Food Chem, 2021, 69(10):3060-3068. DOI: 10.1021/acs.jafc.0c07640.
[12] Aslan BT, Ertugrul B, Iplik ES, et al. Apoptotic effects of acacetin in human colon cancer HT-29 and HCT 116 cells[J]. J Cancer Res Ther, 2021, 17(6):1479-1482. DOI: 10.4103/jcrt.JCRT_1097_19.
[13] Esmeeta A, Adhikary S, Dharshnaa V, et al. Plant-derived bioactive compounds in colon cancer treatment: an updated review[J]. Biomed Pharmacother, 2022, 153:113384. DOI: 10.1016/j.biopha.2022.113384.
[14] Feng J. The p53 pathway related genes predict the prognosis of colon cancer[J]. Int J Gen Med, 2022, 15:169-177. DOI: 10.2147/IJGM.S346280.
[15] Zhang Z, Li K, Zheng Z, et al. Cordycepin inhibits colon cancer proliferation by suppressing MYC expression[J]. BMC Pharmacol Toxicol, 2022, 23(1):12. DOI: 10.1186/s40360-022-00551-z.
[16] Chen Y, Hao E, Zhang F,et al. Identifying active compounds and mechanism of camellia nitidissima chi on anti-colon cancer by network pharmacology and experimental validation[J]. Evid Based Complement Alternat Med, 2021:7169211. DOI: 10.1155/2021/7169211.
[17] Luan Y, Luan Y, Zhao Y,et al. Isorhamnetin in Tsoong blocks Hsp70 expression to promote apoptosis of colon cancer cells[J]. Saudi J Biol Sci, 2019, 26(5):1011-1022. DOI: 10.1016/j.sjbs.2019.04.002.
[18] Tu F, Li M, Chen Y, et al. Let-7i-3p inhibits the cell cycle, proliferation, invasion, and migration of colorectal cancer cells via downregulating CCND1[J]. Open Med (Wars), 2022, 17(1):1019-1030. DOI: 10.1515/med-2022-0499.
[19] Zhao J, Leng P, Xu W,et al. Investigating the multitarget pharmacological mechanism of ursolic acid acting on colon cancer: a network pharmacology approach[J]. Evid Based Complement Alternat Med, 2021, 2021:9980949. DOI: 10.1155/2021/9980949.
[20] Coomans de Brachène A, Demoulin JB. FOXO transcription factors in cancer development and therapy[J]. Cell Mol Life Sci, 2016, 73(6):1159-72. DOI: 10.1007/s00018-015-2112-y.
[21] Chen JF, Wu SW, Shi ZM,et al. Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action[J]. Chin Med, 2023, 18(1):14. DOI: 10.1186/s13020-023-00719-7.
[22] 朱建秋,罗幸,谢迎秋,等. MSCs通过抑制PI3K/Akt信号通路减轻VAP肺损伤的作用研究[J]. 国际医药卫生导报,2024,30(4):597-601. DOI:10.3760/cma.j.issn.1007-1245.2024.04.015.
|